Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.


Abstract

These data indicate that telomestatin potently eradicates GSCs through telomere disruption and c-Myb inhibition, and this study suggests a novel GSC-directed therapeutic strategy for GBMs.


Full Text

  • DOI - Clinical cancer research : an official journal of the American Association for Cancer Research (DOI)
  • HighWire Press - full-text online

Subjects


Similar articles

Authors


Publication date

2012-03-05


Journal

Clinical cancer research
Clin Cancer Res (1078-0432)

Journal topics


Language

Eng.


Copyright

Clinical cancer research : an official journal of the American Association for Cancer Research

Department of Neurological Surgery, Dardinger, Center for Neuro-oncology, James Cancer Hospital and The Ohio State University, Columbus, Ohio 43210, USA.


Release reference

Clin Cancer Res. 2012 Mar;18(5):1268-80



Related books


Español | English

© Galenicom 1999-2013